JENTIN MET XR 50/1000MG TABLET

Jentin Met XR 50/1000mg Tablet is a combination medication that contains two active ingredients: sitagliptin and metformin. Sitagliptin belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors, and metformin is a biguanide. This combination tablet is used to manage type 2 diabetes mellitus. Jentin Met XR 50/1000mg Tablet is formulated as an extended-release tablet, which means it releases the medication slowly over time to provide continuous blood sugar control throughout the day.

Uses:

1. Type 2 Diabetes Mellitus: Jentin Met XR 50/1000mg Tablet is primarily used to manage type 2 diabetes mellitus, a chronic condition characterized by high blood sugar levels. It is used as an adjunct to diet and exercise to help control blood glucose levels in individuals with type 2 diabetes.

Side Effects:

Jentin Met XR 50/1000mg Tablet may cause certain side effects in some individuals. Common side effects can include:

1. Gastrointestinal Upset: Nausea, vomiting, diarrhea, abdominal discomfort, and loss of appetite are common gastrointestinal side effects.
2. Hypoglycemia: The combination of sitagliptin and metformin may cause low blood sugar levels (hypoglycemia), especially if taken with other diabetes medications. Symptoms of hypoglycemia include sweating, tremors, dizziness, confusion, and palpitations.
3. Headache: Some individuals may experience headaches while taking Jentin Met XR 50/1000mg Tablet.
4. Upper Respiratory Tract Infection: It is possible to experience upper respiratory tract infections, such as the common cold or sore throat, while taking this medication.

It is important to note that not all individuals will experience these side effects, and they are generally mild and temporary. However, if any side effects persist or worsen, it is advisable to consult a healthcare professional.

When Not to Use:

Jentin Met XR 50/1000mg Tablet should not be used in the following situations:

1. Type 1 Diabetes: This medication is not indicated for the treatment of type 1 diabetes, as it primarily targets the insulin resistance seen in type 2 diabetes.
2. Diabetic Ketoacidosis: Jentin Met XR 50/1000mg Tablet should not be used in individuals with diabetic ketoacidosis, a potentially life-threatening condition characterized by high ketone levels in the blood.
3. Severe Kidney Disease: It is contraindicated in individuals with severe kidney disease or conditions that may lead to kidney dysfunction, as metformin can increase the risk of lactic acidosis.
4. Hypersensitivity: Individuals with a known allergy or sensitivity to sitagliptin, metformin, or any components of the tablet should avoid its use.

It is essential to consult a healthcare professional or pharmacist before starting Jentin Met XR 50/1000mg Tablet, as they can assess your medical history, current medications, and provide appropriate advice and guidance based on your specific situation.